Immunostaining showed that her breast cancer had estrogen receptor (ER) and progesterone receptor (PgR) positivities (both Allred score 8), human epidermal growth factor receptor type 2 (HER2) negativity, and a low Ki-67 labelling index of 5%. This evidence concerns the gene ESR1 and breast cancer.